Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinoma

Clinical Cancer Research

Volumn 9, Issue 2, 2003, Pages 580-585

  Salesiotis, Anastasios ^a   Soong, Richie ^b   Diasio, Robert B ^b   Frost, Andra ^b   Cullen, Kevin J ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ASCORBIC ACID; CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL; METHOTREXATE; RETINOL; THYMIDINE PHOSPHORYLASE;

AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; COST EFFECTIVENESS ANALYSIS; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; METASTASIS; MICROSCOPY; MOUTH CARCINOMA; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; TUMOR BIOPSY; VERRUCOUS CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; BIOPSY; CARCINOMA, VERRUCOUS; DEOXYCYTIDINE; FEMALE; HUMANS; MOUTH NEOPLASMS; PRODRUGS;

EID: 0037316890     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Goethals, P. L., Harrison, E. G., and Devine, K. D. Verrucous squamous carcinoma of the oral cavity. Am. J. Surg., 106: 845-850, 1963.
2. Medina, J. E., Dichtel, W., and Luna, M. A. Verrucous squamous carcinomas of the oral cavity: a clinicopathologic study of 104 patients. Arch. Otolaryngol., 110: 437-440, 1984.
3. McCoy, J. M., and Waldron, C. A. Verrucous carcinoma of the oral cavity: a review of 49 cases. Oral Surg., 52: 623-629, 1981.
4. Rajendran, R., Varghese, I., Sugathan, C. K., and Vijayakumar, T. Ackerman's tumour (verrucous carcinoma) of the oral cavity: a clinicoepidemiologic study of 426 cases. Austral. Dent. J., 33: 295-298, 1988.
5. Bouquot, J. E. Oral verrucous carcinoma. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod., 86: 318-324, 1998.
6. Koch, B. B., Trask, D. K., Hoffman, H. T., Karnell, L. H., Robinson, R. A., Zhen, W., and Menck, H. R. National survey of head and neck verrucous carcinoma. Cancer (Phila.), 92: 110-120, 2001.
7. Elliott, G. B., MacDougall, J. A., and Elliott, J. D. A. Problems of verrucous squamous carcinoma. Ann. Surg., 17: 309-314, 1973.
8. Krishnan Nair, M., Sankaranarayanan, R., and Padmanabhan, T. K. Oral verrucous carcinoma: treatment with radiotherapy. Cancer (Phila.), 61: 458-461, 1988.
9. McGavin, J. K., and Goa, K. L. Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer. Drugs, 61: 2309-2326, 2001.
10. Tanaka, J., Yoshida, K., Takahashi, M., and Suzuki, M. A case of verrucous carcinoma of the tongue, effectively treated with preoperative chemotherapy (UFT, CDDP, PEP) and irradiation. Gan To Kagaku Ryoho, 19: 525-527, 1992.
11. Batsakis, J. G., Suarez, P., and El-Naggar, A. K. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol., 35: 354-359, 1999.
12. Friedell, H. L., and Rosenthal, L. M. The etiologic role of chewing tobacco in cancer of the mouth. J. Am. Med. Assoc., 116: 2130-2135, 1941.
13. Ackerman, L. V. Verrucous carcinoma of the oral cavity. Surgery, 23: 670-678, 1948.
14. Florin, E. H., Kolbusz, R. V., and Goldberg, L. H. Verrucous carcinoma of the oral cavity. Int. J. Dermatol., 33: 618-622, 1994.
15. Kraus, F. T., and Perez-Mesa, C. Verrucous carcinoma: clinical and pathologic study of 105 cases involving oral cavity, larynx and genitalia. Cancer (Phila.), 19: 26-38, 1966.
16. Minielly, J. A., Harrison, E. G., Fontana, R. S., and Payne, W. S. Verrucous squamous cell carcinoma of the esophagus. Cancer (Phila.), 20: 2078-2087, 1967.
17. Ferlito, A., and Recher. G. Ackerman's tumor (verrucous carcinoma) of the larynx. Cancer (Phila.), 46: 1617-1630, 1980.
18. Brownstein, M. H., and Shapiro, L. Verrucous carcinoma of the skin, epithelioma cuniculatum plantare. Cancer (Phila.), 38: 1710-1716, 1976.
19. Miller, C. S., and Johnstone, B. M. Human papilloma virus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod., 91: 622-635, 2001.
20. Batsakis, J. G., and Suarez, P. Papillary squamous carcinoma: will the real one please stand up? Adv. Anat. Pathol., 7: 2-8, 2000.
21. Vidyasagar, M. S., Fernandes, D. J., Kasturi, D. P., Akhileshwaran, K., Rao, K., Rao, S., Rao, R. V., and Solomon, J. G. Radiotherapy and verrucous carcinoma of the oral cavity: a study of 107 cases. Acta Oncol., 31: 43-47, 1992.
22. Proffit, S. D., Spooner, T. R., and Kosek, J. C. Origin of undifferentiated neoplasm from verrucous carcinoma of the oral cavity following irradiation. Cancer (Phila.), 26: 389-393, 1970.
23. Perez, C. A., Kraus, F. T., Evans, J. C., and Powers, W. E. Anaplastic transformation in verrucous carcinoma of the oral cavity after radiation therapy. Radiology, 86: 108-115, 1966.
24. McDonald, J. S., Crissman, J. D., and Gluckman, J. L. Verrucous carcinoma of the oral cavity. Head Neck Surg., 5: 22-28, 1982.
25. Taguchi, T. Clinical application of biochemical modulation in cancer chemotherapy: biochemical modulation for 5-FU. Oncology, 54 (Suppl. 1): 12-18, 1997.
26. Tanaka, J., Inuyama, Y., Fujii, M., Takaoka, T., Hosoda, H., and Saito, S. Clinical trials on UFT in the treatment of head and neck cancer. Auris Nasus Larynx, 12 (Suppl. 2): 261-266, 1985.
27. Gonzalez-Larriba, J. L., Garcia Carbonero, I. G., Sastre Valera, J. S., Perez Segura, P., and Diaz-Rubio, E. Neoadjuvant therapy with cisplatin/5-FU vs cisplatin/UFT in locally advanced squamous cell head and neck cancer. Oncology, 11 (Suppl. 10): 90-97, 1997.
28. Blum, J., Jones, S., Buzdar, A., LoRusso, P., Kuter, I., Vogel, C., Osterwalder, B., Burger, H., Brown, C., and Griffin, T. Multicenter Phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J. Clin. Oncol., 17: 485-493, 1999.
29. Hoff, P. M. Capecitabine as first-line treatment for colorectal cancer (CRC): integrated results of 1207 patients (pts) from 2 randomized, Phase III studies. On behalf of the capecitabine CRC study group. Ann. Oncol. 11: 60, 2000.
30. Cunningham, D., and Coleman, R. New options for outpatient chemotherapy-the role of oral fluoropyrimidines. Cancer Treat. Rev., 27: 211-220, 2001.
31. Lamont, E. B., and Schilsky, R. L. The oral fluoropyrimidines in cancer chemotherapy. Clin. Cancer Res., 5: 2289-2296, 1999.
32. Salonga, D., Danenberg, K. D., Johnson, M., Metzger, R., Groshen, S., Tsao-Wei, D. D., Lenz, H., Leichman, C., Leichman, L., Diasio, R., and Danenberg, P. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin. Cancer Res., 6: 1322-1327, 2000.
33. Ishikawa, T., Sekiguchi, F., Fukase, Y., Sawada, N., and Ishitsuka, H. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res., 58: 685-690, 1998.